+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Age: 18Years +
MALE
ID06450106

Phase 1 Study of STM-416p Given During Radical Prostatectomy Surgery for Prostate Cancer in Adult Men

Led by SURGE Therapeutics · Updated on 2026-02-19

18

Participants Needed

4

Research Sites

13 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are conducting a Phase 1 study to evaluate STM-416p, a drug administered during surgery to patients with prostate cancer undergoing radical prostatectomy. This early phase trial focuses on determining the safety and tolerability of STM-416p in this patient population, particularly monitoring dose-limiting toxicities and adverse events up to 90 days after treatment. During the trial, STM-416p will be given intraoperatively as a monotherapy to patients scheduled for radical prostatectomy. The study involves escalating doses to find a safe and tolerable dose. Researchers will also study how the drug moves through and affects the body by measuring pharmacokinetics and pharmacodynamics at various time points after administration. Additionally, surgical wound healing will be assessed on days 7 and 21 post-surgery. Participants will be closely monitored throughout the trial with safety assessments focusing on adverse events and wound healing. Blood samples will be collected to analyze drug levels and immune responses. The total observation period includes safety follow-up up to 90 days post-treatment. Male participants aged 18 and older diagnosed with prostate cancer and eligible for radical prostatectomy will be involved, with detailed evaluations to ensure organ function and performance status meet study requirements.

CONDITIONS

Brief Title

Study of STM-416p Administered to Patients Undergoing Radical Prostatectomy

Research Team

K

Kayti Aviano

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here